Serono Rebif 25% Market Share Expected By 2006; Monthly Price Is $1,156
Serono hopes Rebif will capture a quarter of the multiple sclerosis market by 2006, CEO Ernesto Bertarelli told securities analysts during a March 11 conference call
Serono hopes Rebif will capture a quarter of the multiple sclerosis market by 2006, CEO Ernesto Bertarelli told securities analysts during a March 11 conference call